Shineco announced that its subsidiary, Fuzhou Meida Health Management, has entered into Distribution Agreements for its water-soluble phospholipid concentrate health food beverage with a projected goal of more than $30 million in sales with six distribution companies, for a term of three years. Jennifer Zhan, CEO of Shineco, said, “The Company’s sustained research and development efforts have developed a production process that is expected to open up a potentially vast new market for our health food beverage. We believe that our technologically advanced production process provides a competitive advantage in the marketplace since it achieves a pure physical separation and extraction of the naturally active phospholipids.”
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SISI:
- Shineco Announces New Distribution Agreements for over $30 Million in Sales for its New Health Food Beverage
- Shineco regains compliance with Nasdaq minimum bid price rule
- Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Shineco enters into securities purchase agreement for gross proceeds of $7M
- Shineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of $7.0 Million